Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Furness

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|May 17, 2019
Endovascular mechanical thrombectomy for superior sagittal sinus thrombosis in a patient with T-lymphoblastic lymphoma treated with L-asparaginaseAdam Bond, Caroline Furness, Alex Mortimer
BMJ (Clinical Research Ed.)|September 25, 2004
Morbilliform rashCaroline Furness, Rita Sharma, Anthony Harnden
Leukemia & Lymphoma|October 4, 2019
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use dataCatherine S Y Lecat, Caroline Besley, Rachael E Hough, et al.
British Journal of Haematology|June 16, 2021
COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experienceGiovanna Lucchini, Caroline Furness, Sarah Lawson, et al.
British Journal of Haematology|July 1, 2026
Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK studyGiorgio Ottaviano, Emanuele Lanino, Zohreh Nademi, et al.
Transplantation and Cellular Therapy|December 16, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3<sup>+</sup> T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow GraftsSu Han Lum, Beki James, Giorgio Ottaviano, et al.
Blood Advances|January 17, 2023
T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancyClaire Horgan, Khushnuma Mullanfiroze, Archana Rauthan, et al.
Leukemia|August 9, 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AMLJad Othman, Nicola Potter, Katya Mokretar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|May 17, 2019
Endovascular mechanical thrombectomy for superior sagittal sinus thrombosis in a patient with T-lymphoblastic lymphoma treated with L-asparaginaseAdam Bond, Caroline Furness, Alex Mortimer
BMJ (Clinical Research Ed.)|September 25, 2004
Morbilliform rashCaroline Furness, Rita Sharma, Anthony Harnden
Leukemia & Lymphoma|October 4, 2019
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use dataCatherine S Y Lecat, Caroline Besley, Rachael E Hough, et al.
British Journal of Haematology|June 16, 2021
COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experienceGiovanna Lucchini, Caroline Furness, Sarah Lawson, et al.
British Journal of Haematology|July 1, 2026
Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK studyGiorgio Ottaviano, Emanuele Lanino, Zohreh Nademi, et al.
Transplantation and Cellular Therapy|December 16, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3<sup>+</sup> T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow GraftsSu Han Lum, Beki James, Giorgio Ottaviano, et al.
Blood Advances|January 17, 2023
T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancyClaire Horgan, Khushnuma Mullanfiroze, Archana Rauthan, et al.
Leukemia|August 9, 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AMLJad Othman, Nicola Potter, Katya Mokretar, et al.
Pageof 1